Abnormally expressed LPAR6 can activate the protooncogene pim-3 via the signal transducers and activators of transcription 3 (STAT3) binding site, thereby maintaining the tumor proliferative capacity and tumorigenic capacity of HCC 76. Here, LPAR6 is linked to hepatocellular carcinoma.